Contest Details
Maker in China SME Innovation and Entrepreneurship Global Contest
2nd Runner-up

Liquid Biopsy for cancer monitoring and early screening

Company Details
Region Of Origin Founder
Hong Kong
Cyberport Community Status
Business Details
Technology Sector

Cellomics is a leading Hong Kong-based biotech company focusing on the development and commercialisation of liquid biopsy products and services for early screening and disease management of cancer. With proprietary microfluidics and nucleic acid detection technology, we offer comprehensive liquid biopsy solutions for precision oncology. Our innovative products for circulating tumor cell enrichment and genetic analysis are manufactured in ISO13485 certified facilities and approved for clinical use in the China market. Cellomics aspires to become a global leader in liquid biopsy and precision medicine, and looks forward to working with international partners to help doctors and
patients in fighting the battle with cancer.

About iStartup

iStartup@HK, a one-stop platform run by Cyberport, is designed to connect tech start-ups to investors and users seeking innovative solutions. Through this virtual-pitching channel, tech companies can showcase their profile and products to attract funding and expand their business footprint.

    cyberport@HK logo